You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD6094

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Cancer Trial in Ruddington (AZD6094 (Savolitinib) film coated tablets 600 mg, [14C]-AZD6094 (Savolitinib) Solution for Infusion,

Completed
  • Cancer
  • AZD6094 (Savolitinib) film coated tablets 600 mg
  • +2 more
  • Ruddington, United Kingdom
    Research Site
Jan 25, 2021

Papillary Renal Cell Cancer Trial in Worldwide (AZD6094)

Completed
Has Results
  • Papillary Renal Cell Cancer
  • AZD6094
  • Birmingham, Alabama
  • +22 more
Mar 23, 2021

Solid Tumors Trial in Baltimore (AZD6094 200 mg, Placebo, Moxifloxacin)

Completed
  • Solid Tumors
  • AZD6094 200 mg
  • +2 more
  • Baltimore, Maryland
    Research Site
Feb 19, 2020

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, Docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Dec 26, 2019

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
Has Results
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023

NSCLC Trial in Guangzhou (Volitinib, gefitinib)

Completed
  • Non-Small Cell Lung Cancer
  • Guangzhou, China
    Guangdong General Hospital
Apr 20, 2020

Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)

Not yet recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • Orange City, Florida
  • +78 more
Jul 20, 2022

NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))

Recruiting
  • Non-small Cell Lung Cancer
  • Durvalumab (MEDI4736)
  • +5 more
  • Marseille, France
    Assistance Publique Hopitaux de Marseille
Sep 21, 2022

Bioequivalence Trial in Shanghai (Savolitinib Test Preparation, Savolitinib Reference Preparation)

Completed
  • Bioequivalence
  • Savolitinib Test Preparation
  • Savolitinib Reference Preparation
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
May 15, 2019

Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

Recruiting
  • Carcinoma
  • La Jolla, California
  • +95 more
Feb 1, 2023

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
Has Results
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022